A group of experts have started investigating the health of a Volunteer during clinical trials of the Covid-19 vaccine at Oxford University and AstraZeneca. Even though this development has slowed the speed of the vaccine, scientists are considering it as good.
However, the World Health Organization (WHO) has said that there is no need to get frustrated or disappointed by the incident. This happens in vaccine trials. Meanwhile, the Oxford Trial Serum Institute of India has stopped the ongoing vaccine in India.
100 volunteers have been vaccinated in India so far
The vaccine Kovyshield developed by Oxford University and AstraZeneca is running combined trials of Phase-2 and Phase-3 in India. The Doing Serum Institute of India has also stopped trials in India.
So far in India, 100 volunteers have been vaccinated under trials. It is planned to enroll 1,600 volunteers to complete the trial. Meanwhile, the Drug Regulator of India has sent a show-cause notice to the Serum Institute.
WHO said- it's no shock
WHO Chief Scientist Soumya Swaminathan in Geneva said the braking of the vaccine trials of Oxford and AstraZeneca is not a shock. This suggests that the process of vaccine manufacture is not always the same as "fast and straight road".
Swaminathan said it was good. We can also consider it a wake-up call. It is a lesson to all that research has its ups and downs. The same happens in clinical development. We have to be ready for that.
At the same time, the CEO of AstraZeneca has claimed that the volunteer who received the neurological problem was given the actual vaccine. Not dummy It is not yet understood whether the vaccine that causes the neurological disorder affecting the spine cod.
AstraZeneca CEO Pascal Soriot said that even after what happened, his vaccine could still be in the market by the end of this year. He assured the company's investors that this break was temporary. Soon the trials will gain momentum.
There will be trials of nasal spray vaccine in China
China has approved its first nasal spray vaccine for trials. The clinical trials of phase-1 will begin in November. In this, this nasal spray vaccine will be tried on 100 volunteers.
According to the report of the Chinese government newspaper Global Times, this nasal vaccine is a joint effort of Hong Kong and China. This includes researchers from the University of Hong Kong, Xiamen University, and Beijing Wantai Biological Pharmacy.
If the nasal spray vaccine contains influenza virus ie H1N1, H3N2, and B, it can give double protection against influenza and novel coronavirus. It may take a year to complete its trials.
Chinese company claims our vaccine safe
Meanwhile, the China National Biotech Group company said that no volunteers had any side-effects or adverse reactions even after two shots of its vaccine. Hundreds of people have been vaccinated so far.
The vaccine of China National Biotech Group Company, a subsidiary of Sinopharm Group Company, has been approved for emergency use in China. This vaccine has been introduced to the frontline workers even before the Phase-3 trials are completed.
Covid-19 Vaccine Update
180 vaccines are being made for COVID-19 worldwide.
The 35 vaccine is in the stage of clinical trials. That means their human trials are going on.
Phase-3 trials of 9 vaccines are underway. That is, it will remain in the last phase of all vaccine human trials.
These 9 vaccines include Oxford / AstraZeneca (UK), Moderna (US), Gamalaya (Russia), Janssen Pharma Companies (US), Sinopec (China), Wuhan Institute (China), Beijing Institute (China), Cancino Biologics (China). And Pfizer (US) vaccine.
145 vaccines are in the pre-clinical trials stage. That is, their testing is going on in labs.
Kolkata Case: 'Hang him or do whatever you want...', the accused's mother-in-law said on the rape-murder case of a female doctor
The investigation into the rape and murder of a female doctor at Kolkata's RG Kar Medical College and Hospital is underway. On the other hand, protests are continuing against the incident. Meanwhile,
UP is ready: Preparations to promote Nipun Bharat Mission, a program organized on July 21 in Lucknow
Under the New Education Policy, 2020, the Government of Uttar Pradesh is going to take forward the Basic Literacy and Numeracy (FLN) mission once again. Let us inform you that Uttar Pradesh was the
Samsung reduced the price of this 7000mAh battery smartphone, know what is the new price
The price cut of the smartphone continues on the occasion of the new year. Many companies are cutting the price of their selected handsets. Meanwhile, Samsung has also reduced the price of its
B Praak: B Praak's cryptic post, is the singer targeting Diljit Dosanjh? He said- 'You should be ashamed...'
Punjabi actor-singer Diljit Dosanjh is facing criticism over his upcoming Punjabi film 'Sardar Ji 3', as the film also stars Pakistani actress Hania Aamir. The actor's troubles seem to be increasing
UP Election 2022: Mayawati's rally in Ghaziabad rained heavily on BJP-SP, know what was said?
Because of the UP assembly elections, BSP supremo Mayawati fiercely attacked BJP and Samajwadi Party during a public meeting in Ghaziabad. Speaking from the stage at Kavinagar Ramlila Maidan, he said
Second Day of Parliament Action: Demand to enact population control law in Lok Sabha; Discussion on amendment in Wildlife Protection Act in Rajya Sabha
The winter session of Parliament began on Wednesday, 7 December. This session is going to last for 17 days. During this, the government will present 16 bills in Parliament. On the first day where the
Weather: Heavy rain alert in Uttarakhand-Himachal and UP, forecast of 204.4 mm rainfall; keep an eye on the condition of the center
The difficulties of Himachal Pradesh and Uttarakhand, which are facing devastation due to heavy rains, and landslides, may increase further. The Indian Meteorological Department has predicted heavy to
Corona: Covid patient found again in Guangzhou of China, Dragon imposed a strict ban
On Saturday, several activities were banned and people were asked to stay in their homes after an increase in cases of coronavirus infection in some areas of China's southern province of Guangzhou.
Second indigenous vaccine: Zydus Cadila's 'JayCov-D' approved, will be available to people above 12 years
The country has got the second indigenous anti-corona vaccine. Following the recommendation from the Government Expert Committee, DCGI has given emergency approval for the use of Zydus Cadila's corona
Global Hunger Index 2022: India slips six places to 107th place, Sri Lanka-Pakistan are also better than us
India's position has worsened in the Global Hunger Index 2022. According to the data, India has now slipped six places to 107th position out of 121 countries. Talking about South Asian countries,
